Cargando…
The adverse drug reactions to tumor necrosis factor alpha inhibitor
Autores principales: | Park, Hye-Kyung, Jo, Eun-Jung, Lee, Seung-Eun, Mok, Jung-Ha, Kim, Mi-Hyun, Lee, Kwangha, Kim, Ki-Uk, Lee, Min-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127764/ http://dx.doi.org/10.1186/2045-7022-4-S3-P53 |
Ejemplares similares
-
Clinical efficacy of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in patients with multidrug-resistant bacteremia: a single-center study in Korea
por: Mok, Jeongha, et al.
Publicado: (2019) -
Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non‐small cell lung cancer patients
por: Kim, Insu, et al.
Publicado: (2019) -
Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public–Private Mix Periods
por: Kang, Yewon, et al.
Publicado: (2021) -
Predicting Mortality in Patients with Tuberculous Destroyed Lung Receiving Mechanical Ventilation
por: Kim, Won-Young, et al.
Publicado: (2018) -
Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer
por: Kim, Soo Han, et al.
Publicado: (2023)